BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32588755)

  • 1. Unmet device reprogramming needs at the end of life among patients with implantable cardioverter defibrillator: A systematic review and meta-analysis.
    Gonzalez-Jaramillo V; Sobanski P; Calvache JA; Arenas-Ochoa LF; Franco OH; Hunziker L; Eychmüller S; Maessen M
    Palliat Med; 2020 Sep; 34(8):1019-1029. PubMed ID: 32588755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.
    Hill L; McIlfatrick S; Taylor B; Dixon L; Harbinson M; Fitzsimons D
    Palliat Med; 2015 Apr; 29(4):310-23. PubMed ID: 25239128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advance care planning and end-of-life care in patients with an implantable cardioverter defibrillator: The perspective of relatives.
    Stoevelaar R; Stoppelenburg A; van Bruchem-Visser RL; van Driel AG; Theuns DA; Lokker ME; Bhagwandien RE; Heide AV; Rietjens JA
    Palliat Med; 2021 May; 35(5):904-915. PubMed ID: 33845683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
    Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spouses' reflections on implantable cardioverter defibrillator treatment with focus on the future and the end-of-life: a qualitative content analysis.
    Fluur C; Bolse K; Strömberg A; Thylén I
    J Adv Nurs; 2014 Aug; 70(8):1758-69. PubMed ID: 24321029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.
    Herman M; Horner K; Ly J; Vayl Y
    J Hosp Palliat Nurs; 2018 Feb; 20(1):63-71. PubMed ID: 30063615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, predictors, and outcomes of advance directives in implantable cardioverter-defibrillator recipients.
    Merchant FM; Binney Z; Patel A; Li J; Peddareddy LP; El-Chami MF; Leon AR; Quest T
    Heart Rhythm; 2017 Jun; 14(6):830-836. PubMed ID: 28232262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences of adults living with an implantable cardioverter defibrillator for cardiovascular disease: a systematic review of qualitative evidence.
    Pike A; Dobbin-Williams K; Swab M
    JBI Evid Synth; 2020 Nov; 18(11):2231-2301. PubMed ID: 32813405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing health-related quality of life in patients with an implantable cardioverter defibrillator: A systematic review.
    Wong F; Sit J; Wong E
    JBI Libr Syst Rev; 2012; 10(43):2785-2881. PubMed ID: 27820203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Advance Directive Perspectives and Associations with Preferences for End-of-Life Life-Sustaining Treatments among Patients with Implantable Cardioverter-Defibrillators.
    Kim J; Park HW; An M; Shim JL
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32549238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator.
    Nielsen KM; Zwisler AD; Taylor RS; Svendsen JH; Lindschou J; Anderson L; Jakobsen JC; Berg SK
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD011828. PubMed ID: 30746679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
    Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of One-Year Mortality after Implantable Cardioverter Defibrillator Placement: An Opportunity for Palliative Care?
    Kalver E; Branch-Elliman W; Stolzmann K; Wachterman M; Shin MH; Schweizer ML; Mull HJ
    J Palliat Med; 2023 Feb; 26(2):175-181. PubMed ID: 36067080
    [No Abstract]   [Full Text] [Related]  

  • 15. Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review.
    Palacios-Ceña D; Losa-Iglesias ME; Alvarez-López C; Cachón-Pérez M; Reyes RA; Salvadores-Fuentes P; Fernández-de-Las-Peñas C
    J Adv Nurs; 2011 Dec; 67(12):2537-50. PubMed ID: 21615459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillator devices: when, how and who should discuss deactivation with patients: a systematic literature review.
    Freemantle M; Murtagh F
    BMJ Support Palliat Care; 2022 Dec; 12(4):359-367. PubMed ID: 33963003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence and impact of implantable cardioverter defibrillator shocks in the last phase of life: An integrated review.
    Stoevelaar R; Brinkman-Stoppelenburg A; Bhagwandien RE; van Bruchem-Visser RL; Theuns DA; van der Heide A; Rietjens JA
    Eur J Cardiovasc Nurs; 2018 Aug; 17(6):477-485. PubMed ID: 29772911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Russo JE
    Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.